𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-κB and in vivo toxicity

✍ Scribed by Kei-ichi Sugiyama; Masashi Muroi; Ken-ichi Tanamoto


Book ID
113587803
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
450 KB
Volume
594
Category
Article
ISSN
0014-2999

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A novel NF-κB inhibitor DHMEQ selectivel
✍ Mariko Watanabe; Md. Zahidunnabi Dewan; Takamitu Okamura; Masataka Sasaki; Kinji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i

A non-peptide substance P antagonist (CP
✍ Xu Wang; Steven D. Douglas; Kathryn G. Commons; David E. Pleasure; Jianping Lai; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract Opioids and the neuropeptide substance P (SP) modulate the expression of inflammatory cytokines and chemokines, which are under the control of nuclear factor κB (NF‐κB). We investigated whether the neurokinin‐1 receptor (SP receptor) pathway is biologically involved in morphine‐mediated